Condition: Plasmablastic Lymphoma · Sponsor: Fondazione Italiana Linfomi - ETS
It is an open-label, multicenter, phase II, single arm trial to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients about 28 patients with Relapsed or Refractory Plasmablastic lymphoma.
This description comes directly from the study's public registry record.
Agostino La Porta, Dr. · 059 976 9915 · alaporta@filinf.it
Lorenza Randi, Dr. · 0131033153 · lrandi@filinf.it
Always discuss trial participation with your own doctor first.
| A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona | Ancona, Italy | Recruiting |
| Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati | Aviano, Italy | Recruiting |
| A.O. Spedali Civili di Brescia - Ematologia | Brescia, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia | Florence, Italy | Recruiting |
| Milano - ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia | Miano, Italy | Recruiting |
| Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia | Milan, Italy | Recruiting |
| Monza - ASST MONZA Ospedale S. Gerardo - Ematologia | Monza, Italy | Recruiting |
| Napoli - AORN - Azienda Ospedaliera dei Colli Monald - U.O.C. Oncologia | Naples, Italy | Active Not Recruiting |
| U.O. Ematologia AO di Padova | Padova, Italy | Recruiting |
| A.O. Universitaria Policlinico Giaccone Di Palermo | Palermo, Italy | Not Yet Recruiting |
| Ematologia IRCCS Policlinico S. Matteo di Pavia | Pavia, Italy | Recruiting |
| AO Arcispedale S.Maria Nuova Ematologia | Reggio Emilia, Italy | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04915248